Oramed Pharmaceuticals Inc. financial statements
Oramed Pharmaceuticals Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 2M | 10-K |
| Net income | USD 64.05M | 10-K |
| Cash and equivalents | USD 45.95M | 10-Q |
| Total debt | USD 825K | EODHD |
Oramed Pharmaceuticals Inc. financials on 6ix · Oramed Pharmaceuticals Inc. on 6ix